The appropriate implementation of active surveillance as a management strategy

In addition to the prior article on management of low-risk prostate cancer in Canada comes another article that highlights the importance of what is called “active surveillance” (as opposed to what may actually be much less sophisticated forms of monitoring). … READ MORE …

Active surveillance common in Ontario; less so elsewhere in Canada

Recent data suggest that active surveillance is now becoming a commonplace form of management in the province of Ontario for Canadian men with low-risk forms of prostate cancer. … READ MORE …

Why we should care about standards of care?

“Standard of care” (SOC) is a legalistic term. As it applies to medicine, wh en a clinician follows an SOC, it means that he or she has proceeded with the reasonable caution that any minimally competent doctor would and should exercise in such circumstances. … READ MORE …

Assessing the “value” of treatment with specific drugs (here in the USA)

Last Friday, the National Comprehensive Cancer Cancer Network (NCCN) introduced a new way for doctors and patients to be able to consider the clinical “value” of treatment with specific drugs in specific forms of cancer. How useful this method is will take a while to work out. … READ MORE …

Guidelines and the current treatment of mCRPC

The December 1 issue of The ASCO Post contains two articles that will be of interest to many patients with progressive disease and their family members. … READ MORE …

ASCO endorses guideline on adjuvant, salvage radiation therapy — with a caution

On Tuesday, the American Society of Clinical Oncology (ASCO) gave its backing to a recent guideline on the use of adjuvant and salvage radiotherapy after radical prostatectomy. The ASCO endorsement (by Freedland et al.) appears in the Journal of Clinical Oncology. It is also discussed on the web site ofThe ASCO Post. … READ MORE …

A guide to PSA screening guidelines

For those who would like to have access to a sound summary of the recommendations of groups around the world on screening for prostate cancer, we can recommend a recent, relatively brief, and straightforward review article recently published in BJU International. … READ MORE …